ETF MANAGERS GROUP, LLC - AGIOS PHARMACEUTICALS INC ownership

AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 157 filers reported holding AGIOS PHARMACEUTICALS INC in Q2 2016. The put-call ratio across all filers is 1.22 and the average weighting 0.6%.

Quarter-by-quarter ownership
ETF MANAGERS GROUP, LLC ownership history of AGIOS PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2023$569,587
-17.0%
24,797
+1.5%
0.02%
-43.8%
Q4 2022$685,910
+3.0%
24,427
+3.8%
0.03%
+52.4%
Q3 2022$666,000
+31.6%
23,537
+4.0%
0.02%
+40.0%
Q2 2022$506,000
+28.1%
22,626
+68.1%
0.02%
+87.5%
Q1 2022$395,000
-11.0%
13,458
+1.7%
0.01%
-11.1%
Q4 2021$444,000
-23.7%
13,233
+5.0%
0.01%
-18.2%
Q3 2021$582,000
-6.6%
12,603
+8.3%
0.01%
+10.0%
Q2 2021$623,000
+39.7%
11,634
+28.5%
0.01%
+25.0%
Q1 2021$446,000
+27.8%
9,055
+15.5%
0.01%0.0%
Q4 2020$349,000
+41.9%
7,837
+9.7%
0.01%0.0%
Q3 2020$246,000
-31.7%
7,141
+5.2%
0.01%
-38.5%
Q2 2020$360,000
+150.0%
6,786
+66.5%
0.01%
+85.7%
Q1 2020$144,000
-18.2%
4,076
+11.4%
0.01%
+16.7%
Q4 2019$176,000
+81.4%
3,660
+29.7%
0.01%
+100.0%
Q3 2019$97,000
-31.7%
2,821
-1.1%
0.00%
-40.0%
Q2 2019$142,000
+20.3%
2,851
+63.0%
0.01%
-16.7%
Q1 2019$118,000
+61.6%
1,749
+9.9%
0.01%
+100.0%
Q4 2018$73,000
-31.1%
1,592
+15.7%
0.00%
-25.0%
Q3 2018$106,000
-83.5%
1,376
+11.7%
0.00%
-91.3%
Q2 2018$642,000
+621.3%
1,232
+2.4%
0.05%
+820.0%
Q1 2018$89,000
+41.3%
1,203
+14.2%
0.01%0.0%
Q4 2017$63,000
+5.0%
1,053
+16.6%
0.01%0.0%
Q3 2017$60,000
+42.9%
903
+10.0%
0.01%
+25.0%
Q2 2017$42,000
+27.3%
821
+44.8%
0.00%
-83.3%
Q1 2016$33,0005670.02%
Other shareholders
AGIOS PHARMACEUTICALS INC shareholders Q2 2016
NameSharesValueWeighting ↓
BB BIOTECH AG 2,719,998$155,502,0004.38%
Casdin Capital, LLC 295,000$16,865,0004.11%
Opaleye Management Inc. 130,000$7,432,0002.38%
Opus Point Partners Management, LLC 28,704$1,641,0001.42%
Fernwood Investment Management, LLC 27,550$1,575,0000.84%
Rhenman & Partners Asset Management AB 100,000$5,717,0000.77%
COLUMBIA WANGER ASSET MANAGEMENT LLC 760,116$43,456,0000.65%
Eventide Asset Management 214,000$12,234,0000.64%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 262,984$15,035,0000.59%
CAPITAL GUARDIAN TRUST CO 663,089$37,909,0000.54%
View complete list of AGIOS PHARMACEUTICALS INC shareholders